MYELOABLATIVE TEMOZOLOMIDE INCREASES ANTIGEN-SPECIFIC CD8(+) T-CELL VACCINE RESPONSES AND IS REQUIRED FOR EFFICACIOUS IMMUNOTHERAPY AGAINST INTRACEREBRAL TUMORS
Publication
, Conference
Sanchez-Perez, L; Choi, B; Snyder, D; Cui, X; Schmittling, RJ; Flores, C; Johnson, L; Archer, GA; Bigner, DD; Mitchell, DA; Sampson, JH
Published in: NEURO-ONCOLOGY
October 1, 2012
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2012
Volume
14
Start / End Page
40 / 40
Location
Washington, DC
Publisher
OXFORD UNIV PRESS INC
Conference Name
17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sanchez-Perez, L., Choi, B., Snyder, D., Cui, X., Schmittling, R. J., Flores, C., … Sampson, J. H. (2012). MYELOABLATIVE TEMOZOLOMIDE INCREASES ANTIGEN-SPECIFIC CD8(+) T-CELL VACCINE RESPONSES AND IS REQUIRED FOR EFFICACIOUS IMMUNOTHERAPY AGAINST INTRACEREBRAL TUMORS. In NEURO-ONCOLOGY (Vol. 14, pp. 40–40). Washington, DC: OXFORD UNIV PRESS INC.
Sanchez-Perez, Luis, Bryan Choi, David Snyder, Xiuyu Cui, Robert J. Schmittling, Catherine Flores, Laura Johnson, et al. “MYELOABLATIVE TEMOZOLOMIDE INCREASES ANTIGEN-SPECIFIC CD8(+) T-CELL VACCINE RESPONSES AND IS REQUIRED FOR EFFICACIOUS IMMUNOTHERAPY AGAINST INTRACEREBRAL TUMORS.” In NEURO-ONCOLOGY, 14:40–40. OXFORD UNIV PRESS INC, 2012.
Sanchez-Perez L, Choi B, Snyder D, Cui X, Schmittling RJ, Flores C, et al. MYELOABLATIVE TEMOZOLOMIDE INCREASES ANTIGEN-SPECIFIC CD8(+) T-CELL VACCINE RESPONSES AND IS REQUIRED FOR EFFICACIOUS IMMUNOTHERAPY AGAINST INTRACEREBRAL TUMORS. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2012. p. 40–40.
Sanchez-Perez, Luis, et al. “MYELOABLATIVE TEMOZOLOMIDE INCREASES ANTIGEN-SPECIFIC CD8(+) T-CELL VACCINE RESPONSES AND IS REQUIRED FOR EFFICACIOUS IMMUNOTHERAPY AGAINST INTRACEREBRAL TUMORS.” NEURO-ONCOLOGY, vol. 14, OXFORD UNIV PRESS INC, 2012, pp. 40–40.
Sanchez-Perez L, Choi B, Snyder D, Cui X, Schmittling RJ, Flores C, Johnson L, Archer GA, Bigner DD, Mitchell DA, Sampson JH. MYELOABLATIVE TEMOZOLOMIDE INCREASES ANTIGEN-SPECIFIC CD8(+) T-CELL VACCINE RESPONSES AND IS REQUIRED FOR EFFICACIOUS IMMUNOTHERAPY AGAINST INTRACEREBRAL TUMORS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2012. p. 40–40.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2012
Volume
14
Start / End Page
40 / 40
Location
Washington, DC
Publisher
OXFORD UNIV PRESS INC
Conference Name
17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences